Alvotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Alvotech ( NASDAQ: ALVO ) , a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announces its participation in the Morgan Stanley 22nd Annual Global Healthcare Conference in New York.
| Ticker |
Sentiment |
Impact |
|
ALVO
|
Somewhat Bullish
|
61 %
|
|
TEVA
|
Neutral
|
9 %
|
|
KMDA
|
Neutral
|
9 %
|
|
LTUS
|
Neutral
|
9 %
|
|
MS
|
Neutral
|
9 %
|
